Medical News

RSS

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.

15 Apr 2010

States examine role in health reform implementation, worry over scams

The federal government is turning to states to "to institute key components" of the health overhaul law, "some of which have never existed before."

15 Apr 2010

Better safety performance in health care settings associated with reduced malpractice claims

Reducing the number of preventable patient injuries in California hospitals from 2001 to 2005 was associated with a corresponding drop in malpractice claims against physicians, according to a study issued today by the RAND Corporation.

15 Apr 2010

FDA approves Sagent Pharmaceuticals' two ANDAs to market granisetron

Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the Company's two abbreviated New Drug Applications to market granisetron hydrochloride injection, USP (granisetron), an antiemetic used to prevent nausea and vomiting caused by chemotherapy.

15 Apr 2010

BIOTRONIK launches new Reocor external pacemakers following European CE Mark approval

BIOTRONIK SE & Co. KG today announced the European launch after receiving CE Mark approval for its new Reocor external pacemakers, available in two models for dual and single chamber pacing therapy.

15 Apr 2010

Phase IIa clinical trial results of Serdaxin for treatment of MDD

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system therapeutics, today announced clinical results with its investigational new drug, Serdaxin®for the treatment of major depressive disorder.

15 Apr 2010

After close call, actor Dennis Quaid takes on medical mistakes

USA Today: After nearly losing twin newborns to a medical mistake - adult doses of blood thinners were given to the infants - actor Dennis Quaid has taken up the cause of shedding light on the often invisible issues surrounding patient safety.

15 Apr 2010

SCL provides affordable orthodontic program for children

You've done your taxes and 2009 proved to be a pretty bad year. Your tax return shows just how much less money your family earned, making the possibility of providing orthodontic treatment for your children this year even more distant.

15 Apr 2010

Beckman Coulter awarded new agreement with Premier Purchasing Partners for laboratory systems and supplies

Beckman Coulter, Inc., a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced that effective April 1, 2010, it has been awarded a new agreement with Premier Purchasing Partners, the group purchasing unit of Premier, Inc., to provide a full range of core laboratory systems and supplies. Premier is one of the nation's largest healthcare purchasing networks, with more than 2,300 member hospitals and 64,000 additional healthcare sites.

From Beckman Coulter Diagnostics 15 Apr 2010

Study: Lawsuit fears, peer pressure drives higher costs, more tests

The Associated Press: A quarter of heart doctors order more tests than were necessary, driving up costs, according to a new study. "Most said they weren't swayed by such things as financial gain or a patient's expectations.

15 Apr 2010

Interim data from Avid's florbetapir "Image-to-Autopsy" Phase III study to be presented

Avid Radiopharmaceuticals, Inc. today announced the presentation of interim data from its landmark florbetapir "Image-to-Autopsy" Phase III study. These data come from the first cohort of subjects in the trial and are the first ever Phase III results for an agent designed to image Alzheimer's disease pathology.

15 Apr 2010

Parents' wartime deployment can have an impact on children’s behavioral problems

The current conflicts in Iraq and Afghanistan have resulted in extended and repeated combat-related deployments of U.S. military service members. While much has been reported about the problems, both physical and psychological, many bring back with them, new research out of UCLA shows that the family back home can have issues as well.

15 Apr 2010

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Baxter International Inc. and New York-Presbyterian Hospital/Weill Cornell Medical Center today announced results of an 18-month Phase II clinical study of GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] (marketed as KIOVIG outside of the U.S.) for mild-to-moderate Alzheimer's disease. This marked the first announcement of clinical trial results measuring function and cognition in patients who received uninterrupted GAMMAGARD for a period of 18 months.

From Baxter International Inc. 15 Apr 2010

Patheon adds development and manufacturing softgel capability in Cincinnati facility

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it is adding development and manufacturing softgel capability in its Cincinnati facility, providing the pharmaceutical industry a new contract provider for this popular drug delivery system.

15 Apr 2010

biospace med raises $18M to accelerate market penetration of EOS imaging system in North America and Europe

biospace med announced today that it has raised $18 million to accelerate market expansion in North America and Europe of the company's FDA-cleared EOS ultra-low-dose 2D/3D imaging system.

15 Apr 2010

Swine flu shots important before peak season, say experts

According to reports only 13% of the adult population in Singapore has a natural immunity to H1N1 influenza or influenza A. Communicable Disease Centre (CDC) clinical director Leo Yee Sin led this research and emphasized on the importance of vaccinations with the new three in one vaccines in case of a return of the disease.

15 Apr 2010

New AIGISRx Flat provides antimicrobial protection from CRMD infection

TYRX, Inc. announced today the commercial release of the AIGISRx™ Flat, an antibacterial product that helps provide protection against infections associated with implanted pacemakers and defibrillators.

15 Apr 2010

OHSU awarded $5.8M in ARRA funds to educate health IT professional work force

Oregon Health & Science University has been awarded $5.8 million in American Recovery and Reinvestment Act funds to advance the widespread adoption and meaningful use of health information technology by educating professionals to work in this rapidly growing field.

15 Apr 2010

UCSF: Obesity prevention strategies must start as early as possible

To be a truly comprehensive and successful anti-obesity program, First Lady Michelle Obama's "Let's Move" campaign must include interventions that target pregnant women, infants, and pre-school-age children, UCSF experts say.

15 Apr 2010

Investigators tout fraud convictions in California, Florida and New York

Authorities are crediting their Medicare and Medicaid fraud initiatives for convictions and guilty pleas in California, Florida and New York.

15 Apr 2010

Medical News

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

States examine role in health reform implementation, worry over scams

Better safety performance in health care settings associated with reduced malpractice claims

FDA approves Sagent Pharmaceuticals' two ANDAs to market granisetron

BIOTRONIK launches new Reocor external pacemakers following European CE Mark approval

Phase IIa clinical trial results of Serdaxin for treatment of MDD

After close call, actor Dennis Quaid takes on medical mistakes

SCL provides affordable orthodontic program for children

Beckman Coulter awarded new agreement with Premier Purchasing Partners for laboratory systems and supplies

Study: Lawsuit fears, peer pressure drives higher costs, more tests

Interim data from Avid's florbetapir "Image-to-Autopsy" Phase III study to be presented

Parents' wartime deployment can have an impact on children’s behavioral problems

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Patheon adds development and manufacturing softgel capability in Cincinnati facility

biospace med raises $18M to accelerate market penetration of EOS imaging system in North America and Europe

Swine flu shots important before peak season, say experts

New AIGISRx Flat provides antimicrobial protection from CRMD infection

OHSU awarded $5.8M in ARRA funds to educate health IT professional work force

UCSF: Obesity prevention strategies must start as early as possible

Investigators tout fraud convictions in California, Florida and New York

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News